| 臺大學術典藏 |
2022-03-08T03:43:58Z |
Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy
|
Chen Y.-L.; Tsai C.-L.; Cheng J.C.-H.; Wang C.-W.; SHIH-HUNG YANG; Tien Y.-W.; Kuo S.-H. |
| 臺大學術典藏 |
2022-03-04T05:33:29Z |
Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer
|
Chen W.-Y.; CHEN-TU WU; Wang C.-W.; Lan K.-H.; Liang H.-K.; Huang B.-S.; Chang Y.-L.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-22T03:37:23Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-21T03:52:43Z |
Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: The molecular mechanism and the clinical application
|
JIH-HSIANG LEE; Cheng A.-L.; Lin C.-W.; Kuo S.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:38Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lin C.-H.; Shen C.-Y.; JIH-HSIANG LEE; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; Chen W.-W.; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-21T02:04:31Z |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-�eB-related signaling
|
Kuo S.-H.; Yang S.-H.; Wei M.-F.; Lee H.-W.; Tien Y.-W.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2022-02-18T08:46:57Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEN-CHUAN CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; CHIEN-CHUAN CHEN; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-18T08:46:49Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
Tsai K.-F.; Liou J.-M.; Chen M.-J.; CHIEN-CHUAN CHEN; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:26:08Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; CHIEH-CHANG CHEN; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-18T08:26:07Z |
Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis
|
Han M.-L.; CHIEH-CHANG CHEN; Kuo S.-H.; Hsu W.-F.; Liou J.-M.; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-18T06:29:01Z |
Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis
|
Han M.-L.; Chen C.-C.; Kuo S.-H.; WEN-FENG HSU; Liou J.-M.; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-14T06:28:54Z |
Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma
|
Yang S.-H.; Lin L.-W.; YU-JEN FANG; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:52Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; YU-JEN FANG; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-01-25T02:29:53Z |
Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application
|
LEE JIH-HSIANG; Cheng, A-L; Lin, C-W; Kuo, S-H |
| 臺大學術典藏 |
2022-01-14T03:59:35Z |
Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase?1 inhibition [Strahlenempfindlichkeit beim ?sophagealen Plattenepithelkarzinom: Wirksamkeit des Polo-like-Kinase-1-Inhibitors]
|
Chen J.L.-Y.; JO-PAI CHEN; Huang Y.-S.; Tsai Y.-C.; Tsai M.-H.; Jaw F.-S.; Cheng J.C.-H.; Kuo S.-H.; Shieh M.-J. |
| 臺大學術典藏 |
2022-01-14T03:59:35Z |
Impact of smoking cessation on clinical outcomes in patients with head and neck squamous cell carcinoma receiving curative chemoradiotherapy: A prospective study
|
Chen J.L.-Y.; Shen C.-W.; Wang C.-C.; Huang Y.-S.; JO-PAI CHEN; Chiang C.-H.; Lin Y.-L.; Kuo S.-H.; Wang C.-W. |
| 臺大學術典藏 |
2022-01-14T03:59:34Z |
Efficacy of a programmed death-1 checkpoint inhibitor in a case of cutaneous squamous cell carcinoma harboring mutations of TP53 and BRCA2
|
Ma W.-L.; Chou C.-H.; JO-PAI CHEN; Kuo S.-H. |
| 臺大學術典藏 |
2022-01-12T07:07:24Z |
Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation
|
Chiang Y.; Tsai C.-H.; Kuo S.-H.; Liu C.-Y.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Lin C.-T.; HSIN-AN HOU; Chou W.-C.; Liu J.-H.; Lin C.-C.; Wu S.-J.; Hsu S.-C.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Chou H.-T.; Lu M.-Y.; Yang Y.-L.; Chang H.-H.; Liu M.-C.; Liao X.-W.; Wu J.-K.; Chou S.-C.; Cheng C.-L.; Chen C.-Y.; Tsay W.; Tien H.-F.; Tang J.-L.; Chen Y.-H. |
| 臺大學術典藏 |
2022-01-12T07:07:09Z |
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; HSIN-AN HOU; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-01-10T05:34:05Z |
Lysophosphatidic acid alters the expression profiles of angiogenic factors, cytokines, and chemokines in mouse liver sinusoidal endothelial cells
|
Chou C.-H.; SHUO-LUN LAI; Ho C.-M.; Lin W.-H.; Chen C.-N.; Lee P.-H.; Peng F.-C.; Kuo S.-H.; Wu S.-Y.; Lai H.-S. |
| 臺大學術典藏 |
2022-01-07T00:59:24Z |
Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial
|
Yang W.-C.; Chen Y.-F.; Yang C.-C.; Wu P.-F.; Chan H.-M.; Chen J.L.-Y.; Chen G.-Y.; CHIA-HSIEN CHENG; Kuo S.-H.; Hsu F.-M. |
| 臺大學術典藏 |
2022-01-05T03:36:40Z |
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
|
Yang S.-H.; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; Kuo S.-H.; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2022-01-05T03:36:38Z |
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-�eB-related signaling
|
Kuo S.-H.; Yang S.-H.; Wei M.-F.; Lee H.-W.; Tien Y.-W.; Cheng A.-L.; KUN-HUEI YEH |
| 國立成功大學 |
2022 |
Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
|
Kuo, S.-H.;Yeh, K.-H.;Lin, C.-W.;Liou, J.-M.;Wu, M.-S.;Chen, L.-T.;Cheng, A.-L. |
| 國立成功大學 |
2022 |
Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC)
|
Lu, Lu L.-S.;Wu, Y.-W.;Chang, J.T.-C.;Chang, W.-T.;Chao, T.-H.;Chen, H.H.-W.;Chen, Y.-J.;Cheng, K.-H.;Hsu, W.-L.;Hung, C.-L.;Kuo, S.-H.;Liang, J.-A.;Lin, H.-J.;Liu, P.-Y.;Liu, W.-S.;Liu, Y.-W.;Shueng, P.-W.;Wang, C.-Y.;Hou, C.J.-Y.;Chiou, J.-F.;Force, TASTRO-TSOC Cardio-Oncology Task |
